Business Credit Report
OBTAIN A CREDIT REPORT AND GET IN-DEPTH INFORMATION ON POTENTIAL CUSTOMERS
CHOOSE FROM THE TWO TYPES OF CREDIT REPORTS :
COMPREHENSIVE IN-DEPTH PRODUCT DESIGNED FOR YOUR CREDIT RISK MANAGEMENT
- Full Report - gives you a comprehensive and in-depth information of your business partners. Full Reports are available in 195 countries. As an optional addition to our Full Report, our Risk Monitoring warns you as soon as there are any changes across more than 20 indicators (including company details, financial data, ownership, payment behavior, etc.), and also of any changes to the Credit Score, the Coface Adjustment, and/or the Recommended Maximum Credit.
- Snapshot Report - gives you a synthetic view of your business partners. The Snapshot Report includes a Quick Rate (“Low”, “Medium”, or “High”), the Coface Adjustment, and a Recommended Maximum Credit. This monitoring focuses on any event relating to the deterioration of the company’s situation, such as insolvency, late payments, Quick Rate, and Coface Adjustment downgrades.
WHAT DOES THE BUSINESS REPORT CONTAIN?
THREE KEY TAKEWAYS
- Minimize credit risk by selecting ideal suppliers and debtors
- Save time and resources, and focus them on the core activities of your company
- Have a realistic overview of the financial situation of your business partners
COFACE BUSINESS CREDIT REPORT INCLUDES THE FOLLOWING INFORMATION:
- Basic Company Details
- Payment History
- Key Financial Data
- Coface Maximum Credit Recommendation
Delivering a valuable solution…
A Hong Kong pharmaceutical trading house purchases medicines from a number of pharmaceutical manufacturers in China and Europe. It also exports to many retail companies in South East Asia and distributes in Hong Kong. The finance department needs to review and monitor 500 companies to avoid possible losses due to non-delivery of goods by sellers and non-payment of buyers.
Coface provides the trading company with summarised and straightforward information on each of its suppliers and buyers, prepared by Coface’s experts in the form of reports that are reviewed every year.
On the strength of the information in the reports, the company decides to scale back its contract with three suppliers. According to Coface reports, the equity capital of the suppliers would have made them difficult to implement the capital expenditure needed to upgrade an existing medicine required by the new international standard.
The company also stops the 60-day credit terms of 8 retail buyers in one month according to the advice of the credit recommendation in the reports which are provided by professional credit analysts. 5 out of the 8 buyers go bankrupt two months later and the company does not suffer from any loss of payment default due to the early action of credit review.